The FDA is considering allowing compounding pharmacies to make six peptides. Research on wellness peptides like BPC-157 and TB-500 is largely limited to animal studies, with little evidence that ...

Understanding the impact of price controls on drug research and approvals of secondary indications is critical for policy ...

Prediction markets on Kalshi and Polymarket now let people wager money on drug approvals. Kalshi also plans to allow bets on ...

Montek Singh Ahluwalia, former Deputy Chairman of the Planning Commission, told ThePrint that ‘priorities would be decided when the committee meets within the period of three months’.

Explore the NTA's reorganization efforts and the necessity for structural reforms to achieve effective results by 2027.

If the agency follows the committee’s advice, it will issue a rule that would allow the compounds to be sold for any condition.

Background Amidst rapidly ageing European populations there is a growing need to develop pension systems that help support ...

The Infosys co-founder has been the government's go-to technocrat for major digital reforms. Here's a look at the experts ...

A technology leader, a former space scientist, an ex-spymaster, an academic, a former education secretary and a logistics ...

This piece explains how researchers measured Americans' engagement in public life using multimode surveys, address-based sampling and cluster analysis.

Placing local communities at the heart of clinical trials is the key to unlocking true diversity in Alzheimer’s research, experts say.